Literature DB >> 6977725

Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells.

B M Vose, G D Bonnard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977725     DOI: 10.1038/296359a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  26 in total

1.  Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines.

Authors:  B S Packard
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.

Authors:  C L Slingluff; T L Darrow; H F Seigler
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

3.  DR antigen expression on ovarian carcinoma cells does not correlate with their capacity to elicit an autologous proliferative response.

Authors:  M Di Bello; V Lucchini; S Chiari; R Colleoni; N Colombo; A Mantovani; P Allavena
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells.

Authors:  P Allavena; P Lo Presti; M Di Bello; V Lucchini; A Lissoni; G Zanetta; C Mangioni; A Mantovani
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 5.  Biological significance of autologous tumor-killing activity and its induction therapy.

Authors:  A Uchida
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

6.  Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.

Authors:  R Somasundaram; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.

Authors:  R Somasundaram; S G Rao; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.

Authors:  M Vilien; M Troye-Blomberg; P Perlmann; H Wolf; F Rasmussen
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 9.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

10.  Human T-cell cultures with selective autotumor reactivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.